Back to DE Deerfield Management Company, L.P.
ININTERCEPT PHARMACEUTICALS IN
Showing 0 of 6 quarters
Position history for DEDeerfield Management Company, L.P.'s holdings in INTERCEPT PHARMACEUTICALS IN
No. Deerfield Management exited its INTERCEPT PHARMACEUTICALS IN position in Q4 2023. Its Q3 2023 13F listed 98,354,000 shares worth $105.1M. Deerfield Management first reported INTERCEPT PHARMACEUTICALS IN in Q3 2022 and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
—
No position history available for this security.